| top | |
| GLIOBLASTOMA NEWSLETTER | |
Volume 1, Number 18 - 14 November 2002 |
|
|
|
|
|
Contents |
|
|
|
|
| Diagnosis & Evaluation | |
| Integrative Medicine | |
| Overall Management | |
| Psychosocial Aspects | |
| Treatment | |
|
|
|
|
|
|
|
|
|
|
Schlemmer
HP, Bachert P, Henze M, Buslei R, Herfarth KK, Debus J, van KG |
|
|
|
|
|
|
|
|
|
|
|
Bhatia N, Agarwal R Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells Prostate 2001 Feb 1;46(2):98-107 |
|
|
Kenny
FS, Gee JM, Nicholson RI, Ellis IO, Morris TM, Watson SA, Bryce RP,
Robertson JF Effect of dietary GLA+/-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenografts Int J Cancer 2001 May 1;92(3):342-7 |
|
|
Manjari
V, Das UN Effect of polyunsaturated fatty acids on dexamethasone-induced gastric mucosal damage Prostaglandins Leukot Essent Fatty Acids 2000 Feb;62(2):85-96 |
|
|
Diane
L. McKay, PhD and Jeffrey B. Blumberg, PhD, FACN |
|
|
|
|
|
|
|
|
|
|
|
Dennis
Argall Dealing with Brain Tumour http://aplaceof.info/braintumours/dealingwithBT.html |
|
|
Das U A radical approach to cancer 
Med Sci Monit 2002 Apr;8(4):RA79-92
|
|
|
Gary L. Rosner, Walter Stadler, Mark J. Ratain Randomized Discontinuation Design: Application to Cytostatic Antineoplastic Agents Journal of Clinical Oncology, Vol 20, Issue 22 (November), 2002: 4478-4484 |
|
|
Whittle IR, Basu N, Grant R, Walker M, Gregor A Management of patients aged >60 years with malignant glioma: good clinical status and radiotherapy determine outcome Br J Neurosurg 2002 Aug;16(4):343-7 |
|
|
|
|
|
|
|
|
|
|
|
Mark Petticrew,
Ruth Bell, Duncan Hunter |
|
|
|
|
|
|
|
|
|
|
|
Myriam W Ben Arush, Sergey Postovsky, Ronit Elhasid, A Ben-Barak, C
Levine, Joseph F Guilburd Antiangiogenic therapy in pediatric malignancies: experience of the Northern Israel Pediatric Cancer Center ASCO Proceedings, 2002 Annual Meeting, Abstract No. 2926 |
|
|
Blaheta RA, Cinatl J Jr Anti-tumor mechanisms of valproate: a novel role for an old drug Med Res Rev 2002 Sep;22(5):492-511 |
|
|
Bourg
V, Lebrun C, Chichmanian RM, Thomas P, Frenay M Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity Ann Oncol 2001 Feb;12(2):217-9 |
|
|
Driever
PH, Knupfer MM, Cinatl J, Wolff JE Valproic acid for the treatment of pediatric malignant glioma Klin Padiatr 1999 Jul-Aug;211(4):323-8 |
|
|
In
Sil Choi , Se
Hoon Lee, Tae-You Kim, Sun Ha Paek, Suzy Kim, Il Han Kim, Dae Seog Heo,Yung-Jue
Bang, Dong Gyu Kim, Hee-Won Jung, Noe Kyeong Kim Phase II Study of Chemotherapy with ACNU Plus Cisplatin Followed by Cranial Irradiation in Patients with Newly Diagnosed Glioblastoma Multiforme Journal of Neuro-Oncology, 60 (2): 171-176, November 2002 |
|
|
Patchell
RA, Regine WF, Ashton P, Tibbs PA, Wilson D, Shappley D, Young B A phase I trial of continuously infused intratumoral bleomycin for the treatment of recurrent glioblastoma multiforme J Neurooncol 2002 Oct;60(1):37-42 |
|
|
Sasaki
T, Yamazaki K, Yamori T, Endo T Inhibition of proliferation and induction of differentiation of glioma cells with Datura stramonium agglutinin Br J Cancer 2002 Oct 7;87(8):918-23 |
|
|
Sheleg SV, Korotkevich EA, Zhavrid EA, Muravskaya GV, Smeyanovich AF, Shanko
YG, Yurkshtovich TL, Bychkovsky PB, Belyaev SA Local chemotherapy with cisplatin-depot for glioblastoma multiforme J Neurooncol 2002 Oct;60(1):53-9 |
|
